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ORIGINAL ARTICLE Reproductive biology
Effect of fetal or neonatal exposure
to monobutyl phthalate (MBP) on
testicular development and function
in the marmoset
Chris McKinnell1,3, Rod T. Mitchell1, Marion Walker1, Keith Morris1,
Chris J.H. Kelnar2, W. Hamish Wallace2, and Richard M. Sharpe1
1MRC Human Reproductive Sciences Unit, Centre for Reproductive Biology, The Queen’s Medical Research Institute, 47 Little France
Crescent, Edinburgh EH16 4TJ, UK 2Edinburgh Royal Hospital for Sick Children, 9 Sciennes Road, Edinburgh EH9 1LF, UK
3Correspondence address. Tel: þ44-131-242-9113; Fax: þ44-131-242-6231; E-mail: c.mckinnell@hrsu.mrc.ac.uk
background: Fetal exposure of male rats to some phthalates induces reproductive abnormalities, raising concerns for similar effects in
humans. In order to address this in a more appropriate animal model, the aim of the present studies was to investigate the effect of fetal/
neonatal exposure to monobutyl phthalate (MBP) in a non-human primate, the marmoset. In particular, to determine if exposure resulted in
effects at birth, or in adulthood, similar to those in male rats, and whether there was evidence for induction of carcinoma-in-situ (CIS) or
testicular germ cell tumours (TGCT).
methods: Pregnant female marmosets were dosed from 7–15 weeks gestation with 500 mg/kg/day MBP and male offspring studied
at birth (1–5 days; n ¼ 6) or in adulthood (n ¼ 5). In another study, newborn males (n ¼ 5 co-twins) were dosed with 500 mg/kg/day MBP
for 14 days, commencing at 4 days of age.
results: Fetal exposure of marmosets to MBP did not affect gross testicular morphology, reproductive tract development or testoster-
one levels at birth, nor were germ cell number and proliferation, Sertoli cell number or germ:Sertoli cell ratio affected. In two of six MBP-
exposed animals, unusual clusters of undifferentiated germ cells were found, but their signiﬁcance is unclear. Neonatal MBP treatment did not
affect germ cell numbers or differentiation. Fetal exposure to MBP did not affect testis size/morphology, germ cell numbers or fertility in
adulthood. There was no evidence for CIS or TGCT.
conclusions: Fetal exposure of marmosets to MBP does not measurably affect testis development/function or cause testicular dys-
genesis, and no effects emerge by adulthood. Some effects on germ cell development were found, but these were inconsistent and of uncer-
tain signiﬁcance.
Key words: fetal / germ cells / monobutyl phthalate / neonatal / testis
Introduction
Reproductive disorders in newborn boys (cryptorchidism, hypospadias)
and young men [low sperm counts, testicular germ cell tumours
(TGCT)] are common and/or increasing in incidence (Skakkebaek
et al., 2001). These disorders are risk factors for each other andmay com-
prise a testicular dysgenesis syndrome (TDS) with a common origin in
fetal life (Skakkebaek et al., 2001; Sharpe and Skakkebaek, 2008). Abnor-
mal testis development leading to altered somatic cell (Sertoli and/or
Leydig cell) function, such as altered testosterone production by the
fetal testis during the period of the male programming window (Welsh
et al., 2008),may underlie TDS disorders (Sharpe and Skakkebaek, 2008).
Evidence suggests that environmental factors/exposures can affect
the risk of TDS (Sharpe and Skakkebaek, 2003). Several studies
have shown that fetal exposure of male rats to a common environ-
mental chemical, di(n-butyl) phthalate (DBP), or to certain other
phthalates, can induce a spectrum of disorders in male offspring
similar to TDS (Mylchreest et al., 2000; Parks et al., 2000; Fisher
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et al., 2003). Human exposure to phthalates such as DBP is ubiquitous
(Silva et al., 2004; CDC, 2005), and exposure during pregnancy
(Marsee et al., 2006) results in fetal exposure (Silva et al., 2004),
raising concerns that this could contribute causally to TDS. In rats,
fetal testosterone production is inhibited by in utero exposure to
DBP (Lehmann et al., 2004; Thompson et al., 2004) or its main metab-
olite monobutyl phthalate (MBP) (Shono et al., 2000). Similarly,
exposure to either DBP (Mylchreest et al., 1998; Fisher et al., 2003)
or MBP (Shono and Suita, 2003; Shono et al., 2005) results in a high
incidence of cryptorchidism, while MBP exposure in rats also results
in reduced fertility in some male offspring (Kai et al., 2005).
While there is indirect evidence to suggest that certain phthalates
could impair fetal testosterone production in humans (Swan et al.,
2005; Swan, 2008), data from in vitro (Hallmark et al., 2007;
Lambrot et al., 2008) and in vivo (Huang et al., 2009) studies suggest
the opposite. Furthermore, fetal testosterone production in mice is
unaffected by DBP, MBP or monoethylhexyl phthalate (MEHP)
(Gaido et al., 2007). In contrast, phthalate effects on germ cell
numbers and/or differentiation in the fetal testis have been shown
in mice (Gaido et al., 2007), rats (Ferrara et al., 2006) and in vitro in
the human (Lambrot et al., 2008). This raises concerns, as impaired
fetal germ cell development underlies the origins of TGCT in
humans (Rajpert-de Meyts, 2006).
Rodents are not good models for human fetal germ cell develop-
ment (Mitchell et al., 2008) and, in view of the contrasting effects of
phthalates on fetal steroidogenesis in rats and mice described
earlier, it is unclear whether the rat is a suitable model for the
human. We have therefore used a non-human primate, the marmoset,
to investigate if phthalate exposure perinatally can affect testis devel-
opment. The marmoset is similar to the human in terms of develop-
mental periods in the male (Kelnar et al., 2002), perinatal germ cell
differentiation (Mitchell et al., 2008) and organisation and (low) efﬁ-
ciency of spermatogenesis (Millar et al., 2000; Sharpe et al., 2000). It
may therefore be a better model for the human than rodents. We
have already shown (Hallmark et al., 2007) that neonatal adminis-
tration of MBP can (transiently) inhibit testosterone production
similar to the fetal effects of DBP in rats (Thompson et al., 2004).
However, there are no reports of testicular effects of fetal exposure
to MBP or other phthalates in the marmoset.
The present studies had two aims. First, to determine if TDS-like
effects, similar to those found in DBP-exposed rats (Fisher et al.,
2003), could be induced in marmosets following fetal or neonatal
exposure to MBP. Second, to determine if fetal MBP exposure
resulted in adverse testicular effects in adulthood, in particular
whether there was evidence of impaired spermatogenesis/fertility or
induction of TGCT or its precursor, CIS. Our results show no
major, consistent effect of MBP exposure on testis and reproductive
development, although some (inconsistent) effects on germ cell devel-
opment need further investigation.
Materials and Methods
Animals, treatments, sample collection
and processing
Animals were captive-bred common marmoset monkeys (Callithrix
jacchus), maintained in a closed self-sustaining colony since 1973. Two
studies were undertaken. In the ﬁrst, nine pregnant females were adminis-
tered 500 mg/kg/day MBP (TCI Europe, Zwijndrecht, Belgium) from
7–15 weeks of gestation. Regular, systematic palpation and/or ultra-
sound were used to diagnose pregnancy and estimate gestational age.
Experience has shown this to be accurate to within one week and was sub-
sequently conﬁrmed by time of birth. A total of 11 male offspring origi-
nated from these treated mothers and were killed either around birth
(1–5 days; n ¼ 6) or in adulthood (n ¼ 5). The treatment time window
was chosen based on comparative analysis of fetal testis development in
the marmoset and human using cell-speciﬁc markers (Mitchell et al.,
2008 and unpublished data) and which indicated that this period will
encompass seminiferous cord formation and onset of testosterone pro-
duction (marmosets have a disproportionately long embryonic period).
This period is thought to correspond to a time window in the rat which
is critical for androgen-dependent programming of reproductive tract mas-
culinisation (Welsh et al., 2008). Animal welfare considerations precluded
the use and treatment of large numbers of animals, so to ensure reason-
able numbers of MBP-treated animals, we restricted the number of control
newborn males (born to vehicle-gavaged pregnant mothers) to n ¼ 3 and
supplemented these with 7 untreated controls to ensure adequate
numbers of controls. These supplementary controls were 1–5 day-old
animals which had been killed because they originated from triplet
births, in which only two animals usually survive. For all parameters inves-
tigated in the present studies, values for the supplementary controls were
comparable to those for the three offspring from vehicle-treated mothers.
For evaluation of testes in adulthood, males exposed in utero to MBP were
compared with control animals (n ¼ 5) of comparable age that were
derived from other experiments (e.g. Lunn et al., 1994, 1997), but
whose mothers had not been treated during pregnancy.
In the second study, 10 newborn marmosets were used, comprising ﬁve
pairs of co-twin males (one vehicle-treated, one MBP-treated), which
enabled pair-wise evaluation using smaller numbers of animals than would
otherwise be necessary (Sharpe et al., 2002). Commencing at 4 days of
age, marmosets were orally administered vehicle or 500 mg/kg/day MBP
for 14 days. The MBP was dissolved in dimethyl sulfoxide then suspended
in honey and was taken voluntarily by infants (Hallmark et al., 2007). MBP
is considered the active metabolite of DBP and can induce the same fetal
testicular effects as DBP in rats (Shono et al., 2000, 2005) and its adminis-
tration to newborn marmosets (at the presently used dose) has been
shown to signiﬁcantly reduce testosterone levels in blood (Hallmark et al.,
2007). MBP was used in the present studies because marmosets are
reported to be poor metabolizers of orally administered phthalate diesters
to their monoesters (Rhodes et al., 1983, 1986). This means that once the
maximum metabolic conversion capacity of a pregnant female marmoset
has been reached after DBP dosing, administration of higher doses will
not result in any furthermetabolism, and therefore exposure, to themonoe-
ster (MBP). Therefore, to ensure maximum possible exposure in the
present studies we administered MBP not DBP. We chose to administer
500 mg/kg/day as this dose of either DBP (Fisher et al., 2003; Mahood
et al., 2007) or MBP (Shono et al., 2000, 2005) causes major adverse
effects on the fetal testis in rats and (MBP) can suppress testosterone
levels in newborn marmosets (Hallmark et al., 2007).
Animals were killed at 1–5 days or 18–21months of age (fetal exposure)
or 4 h after the last (neonatal) treatment, via intraperitoneal injection of an
overdose of sodium pentobarbitone (Euthatal; Rhone Merieux Ltd, Harlow,
UK). Testes were dissected out, ﬁxed for 6 h in Bouin’s ﬁxative, weighed,
then transferred to 70% ethanol and processed into parafﬁn wax in a
Leica automatic processor (Leica Microsystems, Milton Keynes, UK).
For all studies, animals were treated humanely and with regard for allevia-
tion of suffering. Studies were performed according to the Animal (Scientiﬁc
Procedures) Act 1986 under UKHomeOfﬁce Project Licence approval, and
also approved by the local ethical committee for studies in primates.
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Plasma levels of testosterone
Plasma testosterone was measured using an ELISA adapted from an earlier
radioimmunoassay, as described previously (Fisher et al., 2003). The limit
of detection was 12 pg/ml.
Immunohistochemistry
Speciﬁc proteins were detected by immunohistochemistry using methods
detailed previously (Fisher et al., 2003; Gaskell et al., 2004; Ferrara et al.,
2006; Hutchison et al., 2008; Mitchell et al., 2008). In the case of
N-Cadherin and SOX9, protocols were optimised using a range of anti-
body dilutions and appropriate positive and negative control tissues. The
antibodies, dilutions and requirement for antigen retrieval are shown in
Table I. Brieﬂy, antigen retrieval used 0.01 M citrate buffer, pH 6.0,
except for SOX9, which required retrieval in 0.5 M glycine and 0.01%
(w/v) EDTA, pH 3.5. Endogenous peroxidase was blocked by incubating
slides in 3% (v/v) H2O2 in methanol and endogenous biotin was
blocked using an avidin/biotin blocking kit (Vector Laboratories Inc.,
Peterborough, UK) according to manufacturer’s instructions. After incu-
bation overnight at 48C with primary antibody, slides were washed in
0.05 M Tris-buffered saline (TBS), pH 7.4, then incubated with appropriate
biotinylated secondary antibody, followed by incubation with streptavidin-
conjugated horseradish peroxidase (Dako, Ely, UK) and visualisation of
immunostaining using diaminobenzidine (Liquid DABþ, Dako).
Double immunostaining using Fast Blue visualisation
VASA/OCT4: after incubation with the primary (VASA) and secondary
antibodies as described earlier, slides were washed in TBS, incubated
with streptavidin-conjugated alkaline phosphatase (Dako) diluted 1:200
in TBS, and immunostaining visualised using 1 mg/ml Fast Blue
(Sigma-Aldrich Ltd, Poole, UK) until staining was optimal. After washing
in TBS, slides were immunostained for OCT4 using DAB visualisation as
described earlier.
Ki67/VASA: immunostaining for Ki67, using DAB detection, was per-
formed as described earlier. Slides were then washed in TBS and immu-
nostained for VASA using Fast Blue as earlier.
To ensure reproducibility of results and accurate comparison of immu-
nostaining between treatment groups, sections from all groups were run in
parallel on at least two occasions. Negative controls were included in each
experiment, for which the primary antibody was replaced with either
peptide-preabsorbed antibody (OCT4) or the appropriate normal
serum (all other antibodies), and in all such cases immunostaining was
absent. Representative sections were photographed using a Provis AX70
microscope (Olympus Optical, London, UK) ﬁtted with a Canon
DS6031 digital camera (Canon Europe, Amsterdam, The Netherlands).
Images were compiled using Photoshop CS2 (Adobe Systems Inc., Moun-
tain View, CA, USA).
Determination of germ cell and Sertoli
cell numbers
Sections were analysed using a Zeiss Axio-Imager microscope (Carl Zeiss
Ltd, Welwyn Garden City, UK) ﬁtted with a Hitachi HV-C20 camera
(Hitachi Denshi Europe, Leeds, UK) and a Prior automatic stage (Prior
Scientiﬁc Instruments Ltd, Cambridge, UK). Image-Pro 6.2 with Stereolo-
ger plug-in software (MagWorldwide, Wokingham, UK) was used to select
random ﬁelds for counting and to place a grid over the tissue. Germ cell
counting used sections double-immunostained for VASA and OCT4 (1–
5 days of age) to label all subpopulations, VASA alone (17–20 days of
age) or sections stained with hematoxylin (adults); in adults, spermatogo-
nia, spermatocytes and round spermatids were counted separately, while
elongate spermatids and spermatozoa were combined. Sertoli cell count-
ing used sections immunostained for SOX9, a Sertoli cell-speciﬁc nuclear
marker (Swain and Lovell-Badge, 1997). Relative cell volume per testis was
ﬁrst determined (Sharpe et al., 2003). The number of ﬁelds counted per
animal (15–75 ﬁelds) was dependent on obtaining a percentage stan-
dard error value of ,5%. Data were converted to absolute volume per
testis by multiplying by testis weight (equivalent to volume), then con-
verted to cell number per testis after determination of mean cell
nuclear diameter and volume (average of 70–100 nuclei) using the Stereo-
loger software nucleator function. For elongate spermatids and spermato-
zoa, only cell volume per testis was calculated due to extreme variation in
shape of the nucleus.
Determination of the germ cell PI
PI was determined stereologically on sections double-immunostained for
Ki67/VASA, which enabled identiﬁcation of both proliferating and non-
proliferating germ cells. A total of 150 germ cells, from two sections
per animal, were counted. The proliferation index (PI) was calculated as
.............................................................................................................................................................................................
Table I Antibodies and conditions used for immunohistochemistry
Antigen Source Species Dilution Retrieval Target
3b-HSDa Gift Rabbit 1:800 N Leydig cells
SMAb Sigma Mouse 1:1000 N Peritubular myoid cells
Cytokeratin Santa Cruz Mouse 1:500 Y Sertoli cells
AMHc Santa Cruz Goat 1:1000 N Sertoli cells
OCT4 Santa Cruz Goat 1:40 Y Undifferentiated gonocytes
C-KIT Dako Rabbit 1:20 Y Undifferentiated gonocytes
AP-2g Santa Cruz Mouse 1:40 Y Undifferentiated gonocytes
VASA Abcam Rabbit 1:200 Y Germ cells
N-Cadherin Zymed Mouse 1:200 Y Cell adhesion molecule
SOX9 Chemicon Rabbit 1:100 Y Sertoli cells
Ki67 Dako Mouse 1:40 Y Proliferating cells
a3b-Hydroxysteroid dehydrogenase;bsmooth muscle actin; canti-Mu¨llerian hormone.
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the number of Ki67þ/VASAþ cells divided by the number of Ki67þ/
VASAþ plus Ki672/VASAþ cells  100.
Statistical analysis
All data were analysed using the Student’s t-test (two-tailed). Paired t-test
was used for the co-twin study.
Results
Effect of in utero exposure to MBP on
normality of reproductive tract development
Our ﬁndings are summarised in Table II. We compared these with the
incidence of abnormalities observed in our studies in rats (Fisher et al.,
2003: Mahood et al., 2007), and calculated the number of animals
expected to exhibit each abnormality based on a total of n ¼ 11
MBP-exposed male offspring studied and assuming the same percen-
tage incidence as observed in the rat studies. All males exposed
in utero to MBP were normally masculinised at birth and showed no
evidence of hypospadias; this was conﬁrmed when males were killed
either at age 1–5 days (termed ‘at birth’, n ¼ 6) or in adulthood
(18–21 months; n ¼ 5). At birth, testes could be visualised in
transit through the inguinal canal and were similarly placed
in MBP-exposed animals and controls. Plasma testosterone levels in
MBP-exposed animals at birth (2.32+ 0.76 ng/ml; mean+ SEM;
n ¼ 6) were comparable to controls (2.41+0.72 ng/ml; n ¼ 5).
When killed, no gross abnormalities of the epididymis, vas deferens,
prostate or seminal vesicles were apparent in MBP-exposed males
or in controls (data not shown).
Effect of in utero exposure to MBP on testis
morphology and size at birth
Immunohistochemistry for cell-speciﬁc markers was used to evaluate
normality of testis formation/morphology; immunostaining for
smoothmuscle actin (SMA) (Fig. 1A and B) was used to label peritubular
myoid cells, cytokeratin (Fig. 1C and D) and anti-Mu¨llerian hormone
(AMH) (Fig. 1E and F) for Sertoli cells and 3b-hydroxysteroid dehydro-
genase (3b-HSD) for Leydig cells (not shown). Immunostaining for
these markers was comparable in control and MBP-exposed animals
at birth and seminiferous cord formation, size and number and
general testis morphology appeared normal (Fig. 1). Leydig
(3b-HSD-immunopositive) cells were relatively few in number at this
age but were located normally in the interstitium in MBP-exposed
animals and controls. Examination of several sections from each
animal revealed no malformed cords or foci of dysgenesis (Table II).
Testis weight was also comparable in the two groups (Table III). Only
one unusual morphological feature was found in two MBP-exposed
animals. On testis sections immunostained for AMH, large unstained
areas within seminiferous cords were noted which were occupied by
germ cell clusters (Fig. 2A), so these were investigated in more detail.
.................................
........................................................................................
Table II Expected number of MBP-exposed
marmosets exhibiting testicular or reproductive tract
abnormalities, based on the incidence induced in rat
studies using the same dose of the parent compound
DBPa
Abnormality Incidence in
rat studiesb
Number of affected
marmosetsc
Expected Observed
Hypospadias 17% 2 0
Cryptorchidism 70% 7 0
Small testes/impaired
spermatogenesis
70% 7 0
Focal testicular
dysgenesis
50% 5 0
aAs MBP is considered to be the active moiety, exposure of the marmosets to MBP
should have been at least equivalent (and probably more) to that in rats administered
the same dose of DBP; bIncidence observed in previous studies (Fisher et al., 2003;
Mahood et al., 2007); cExpected number based on 11 MBP-exposed offspring studied at
birth or in adulthood and assuming the same % incidence as found in our rat studies.
Figure 1 Representative testicular histology and immunoexpres-
sion of smooth muscle actin (SMA) (A and B), cytokeratin (C and
D) and anti-Mu¨llerian hormone (AMH) (E and F) in 1–5-day-old mar-
mosets after fetal exposure to 500 mg/kg/day MBP or in controls.
Immunoexpression of all three proteins in MBP-exposed animals was
comparable to controls. Seminiferous cord structure and size
appeared normal, with no evidence of focal dysgenesis. Sertoli cell
differentiation and function was similarly unaffected. Bar ¼ 50 mm.
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Germ cell aggregation/clusters at birth
in MBP-exposed animals
Immunostaining of serial testis sections with AMH (Fig. 2A), OCT4
(Fig. 2B), AP2g and C-KIT (not shown) conﬁrmed the presence of
unusual clusters of germ cells in the two aforementioned MBP-exposed
animals. Almost all of the germ cells in these clusters were immunoposi-
tive for OCT4 (Fig. 2B), AP2g and C-KIT (not shown), indicating that
they were undifferentiated gonocytes. In one animal, several clusters
were observed in every section examined from different regions of
both testes; in the second animal, clusters were less frequent but dis-
tributed in different parts of the testis. Germ cell clusters were also
observed in sections from 2 of 10 control animals, but were much
fewer in number, sporadic and much smaller in size. In the two
MBP-exposed animals, the clusters typically contained 10–20 germ
cells, but clusters of up to 27 germ cells were found. In controls, clus-
ters rarely contained more than 10 germ cells.
Abnormal germ cell aggregation occurs in the centre of seminifer-
ous cords in fetal testes of DBP-exposed rats, due to withdrawal of
Sertoli cell cytoplasm from around the germ cells (Kleymenova
et al., 2005). We investigated this using immunochemistry for the
adhesion protein N-Cadherin (Johnson and Boekelheide, 2002). This
showed N-Cadherin immunoexpression in MBP-exposed animals
with germ cell clusters comparable to controls (Fig. 2C), suggesting
that cell–cell adhesion in clusters was normal. Immunostaining of
serial sections with OCT4 and Ki67 revealed no clusters of Ki67þ
cells corresponding to OCT4þ cell clusters (data not shown), ruling
out the possibility that clusters resulted from unusual germ cell pro-
liferation. The etiology of the germ cell clusters therefore remains
unexplained. Multinucleated gonocytes are induced by DBP treatment
of rats (Kleymenova et al., 2005), but none were found in
MBP-exposed marmosets or controls.
Effect of in utero exposure to MBP on germ
cell numbers and differentiation at birth
The neonatal marmoset testis contains a mixed complement of germ
cells, some expressing the pluripotency marker OCT4, others expres-
sing the differentiation marker VASA, and a small population
expressing both (Mitchell et al., 2008). This enables distinction of
the least differentiated gonocytes (OCT4þ/VASA2) from the most
differentiated spermatogonia (OCT42/VASAþ) with some germ
cells intermediate (OCT4þ/VASAþ). Double immunostaining for
OCT4 and VASA was therefore used to identify all germ cells for
counting and to discriminate the relative proportions of undifferen-
tiated versus differentiated germ cells.
Total germcell number per testis varied considerably between animals,
ranging from 0.12 to 0.56  106 in controls and from 0.29 to 0.84  106
in MBP-exposed animals. The majority of germ cells in both groups were
VASAþ (Fig. 3A), while OCT4þ/VASAþ cells comprised only 1–2% of
the total (not shown). There was no signiﬁcant difference in numbers
of VASAþ cells, OCT4þ cells or in total germ cell number per testis in
MBP-exposed animals compared with controls (Fig. 3A).
Germ cell differentiation, quantiﬁed by expressing OCT4þ germ
cells as a percentage of the total germ cell population, varied widely
(0.4–28.9%) between control animals. There was no signiﬁcant
change in MBP-exposed animals, although in one animal, the percen-
tage of OCT4þ cells was far above the control range (5 the mean
control value) (Fig. 3B).
Double immunohistochemistry for Ki67 and VASA was used to
determine the PI in VASAþ germ cells. BecauseOCT4þ germ cells com-
prised on average only 12% of the total at this age, and because of the
difﬁculty in labelling their nuclei for both Ki67 and OCT4, we did not
determine PI in OCT4þ cells. In testes from control animals, the
mean PI of VASAþ cells was 28% (Fig. 4), with marked variation
between animals. There was no signiﬁcant effect of MBP exposure on
VASAþ germ cell proliferation (Fig. 4), although in one MBP-exposed
animal the PI was unexpectedly high and more than double the mean
control value. This was not one of the animals described earlier in
which we found extensive germ cell clustering.
Effect of in utero exposure to MBP on Sertoli
cell number and the germ cell:Sertoli cell
ratio at birth
Sertoli cell number in controls was 4  106 per testis and was unaf-
fected by MBP exposure (Fig. 5A). There was a non-signiﬁcant trend
.............................................................................................................................................................................................
Table III Testis and body weights (means+ SEM) in the marmosets used for the present studies, and in other
(unquantiﬁed) adults for comparison
Treatment Age at evaluation No. of animals Testis wt (mg) Body wt (g)
Controls (vehicle-treated) 1–5 days 3 5.5+0.8 29.7+1.0
Controls (non-treated) 7 4.7+0.4 29.0+1.9
Controls (combined) 10 4.9+0.6 29.2+1.3
MBP 500 mg/kg/day 6 4.8+0.6 29.3+1.9
Controls (vehicle-treated)a 17–20 days 5 11.5+0.9 56.8+4.1
MBP 500 mg/kg/daya 5 11.0+0.8 51.8+3.8
Controls (quantiﬁed)b Adult 5 522+85 366+15
Controls (not quantiﬁed)c 12 516+9 388+17
Controls (combined) 17 518+24 381+13
MBP 500 mg/kg/day 5 605+34 411+21
aCo-twin males; bUntreated control adults most closely age-matched to MBP-exposed animals; cData from other untreated adults, showing that quantiﬁed adults are representative.
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towards an increase in the germ cell:Sertoli cell ratio in MBP-exposed
animals (Fig. 5B). However, in one MBP-exposed animal, the ratio was
well outside the control range (3 the mean control value). This
animal had the lowest number of Sertoli cells in the MBP-exposed
group and the highest number of germ cells and was the animal
(described earlier) in which the most extensive clustering of germ cells
was found.
Effect of neonatal treatment with MBP on
germ cell numbers and differentiation
Because there was 12 weeks between cessation of fetal treatment
and evaluation (around birth), during which MBP effects might disap-
pear, we also studied male co-twin marmosets treated with vehicle
or 500 mg/kg/day MBP for 14 days. Testis weights in MBP-treated
co-twins were comparable to controls (Table III). In control co-twins,
OCT4 expression fell dramatically compared with animals at birth,
with OCT4þ cells either absent or occurring only sporadically in
control testes. MBP-treated co-twins were comparable to controls
(not shown), suggesting no effect on germ cell differentiation neona-
tally. Total germ cell number was determined by quantifying VASAþ
cells, and in controls this gave a mean (+SEM; n ¼ 5) value of
1.63+0.20  106 (Fig. 6), indicating a 2.5-fold increase in germ cell
number compared with values at birth (Fig. 3A). Germ cell number
was reduced by 45 and 35% in two out of ﬁve co-twins exposed neo-
natally to MBP, when compared with their control co-twins, but was
increased by 25% in another MBP-exposed co-twin (Fig. 6). Overall,
there was no signiﬁcant difference between control and MBP-treated
co-twins (Fig. 6). There was no straightforward relationship between
testis weight and germ cell number in individual animals.
Effect of in utero exposure to MBP on the
adult marmoset testis and fertility
To determine if in utero exposure to MBP had any long-term effects on
the marmoset testis or on fertility, some animals were evaluated in
adulthood by comparing them with (control) animals previously
used in other experiments. All testes were scrotal in MBP-exposed
animals (Table II) and testicular morphology was completely normal
(Fig. 7); testis weights were also comparable to controls (Table III).
Examination of sections from different parts of both testes from
each animal revealed no abnormal seminiferous tubules or foci of dys-
genesis (Table II). Quantiﬁcation of germ cells conﬁrmed normal sper-
matogenesis in MBP-exposed animals (Table II), with no effect on
numbers of different germ cell types (Fig. 8). Immunohistochemistry
for OCT4 was used to look for presence of fetal-like germ cells,
but none were detected in testes from control or MBP-exposed
animals. Fertility was assessed in three MBP-exposed animals and
was normal, but was not investigated in others.
Discussion
The aim of this study was to determine if fetal or neonatal exposure of
male marmosets to MBP resulted in effects on testicular (focal dysgen-
esis, effects on Sertoli and germ cells) and reproductive tract (epididy-
mal or penile abnormalities, testis maldescent) development similar to
those found in rats exposed to phthalates, when studied either at birth
or in adulthood. As male marmosets exhibit similar phases of testis
development (McKinnell et al., 2001; Kelnar et al., 2002) and germ
cell differentiation (Mitchell et al., 2008) to the human, whereas
rodents show pronounced differences, the marmoset may be a
better model than rodents for study of MBP effects. In particular,
differences in germ cell differentiation between humans and marmo-
sets on the one hand and rodents on the other hand, suggest that
marmosets could be susceptible to induction of CIS (the precursor
of TGCT in humans) unlike the rat (Mitchell et al., 2008). Therefore,
Figure 2 Appearance of germ cell clusters observed in a 1–
5-day-old marmoset after fetal exposure to 500 mg/kg/day MBP.
Serial testicular sections were immunostained for anti-Mu¨llerian
hormone (AMH) (A) and OCT4 (B). Arrows indicate AMH2 areas
within seminiferous cords corresponding to clusters of OCT4þ
germ cells. N-Cadherin immunoexpression (C) in the same
MBP-exposed animal was comparable to controls and immunonega-
tive areas were absent. Bar ¼ 50 mm.
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one focus of our studies was on perinatal germ cell differentiation.
Treatment of pregnant marmosets for 7 weeks with a high dose of
MBP did not induce any of the testicular or reproductive tract abnorm-
alities in male offspring seen in similar experiments in rats (after DBP
treatment), although there was limited, and inconclusive, evidence for
effects on germ cells perinatally. No CIS or abnormalities in germ cell
numbers or fertility were found in adult marmosets exposed fetally to
MBP.
Several studies have shown that administration of DBP, or certain
other phthalates, to pregnant rats induces TDS-like effects in male off-
spring (Parks et al., 2000; Mylchreest et al., 2000; Fisher et al., 2003).
Defects found neonatally include focal areas of seminiferous tubule
dysgenesis (Fisher et al., 2003), abnormal Leydig cell aggregates
(Mahood et al., 2005), occurrence of multinucleated gonocytes and
abnormal gonocyte aggregation (Kleymenova et al., 2005) and
reduced germ cell numbers and delayed gonocyte differentiation
(Ferrara et al., 2006). Using similar immunohistochemical techniques
to these studies in rats, we found no evidence for similar effects in
MBP-exposed marmosets at birth or in adulthood.
One of the major effects of DBP/MBP exposure in rats is inhibition
of testosterone production by the fetal testis (Shono et al., 2000;
Lehmann et al., 2004) which leads to downstream effects such as
reduced anogenital distance, cryptorchidism and hypospadias in
occasional animals (Foster et al., 2001; Fisher et al., 2003) and
reduced Sertoli cell number at birth (Scott et al., 2007, 2008). We
found no evidence for penile abnormalities or cryptorchidism in
MBP-exposed marmosets either at birth or in adulthood, and Sertoli
cell number was comparable to controls at birth. Although these ﬁnd-
ings do not rule out the possibility that MBP exposure reduced testos-
terone production by the fetal testis during treatment, they show that
if this occurred, it was not sufﬁcient to affect penile development.
Based on rat studies, the critical phase for penile effects due to andro-
gen suppression is during the male programming window, estimated to
be within the MBP treatment period (7–15 weeks gestation) when
extrapolated from rat and human (Welsh et al., 2008) and based on
fetal testis development in the marmoset (Mitchell et al., 2008).
A key focus of the present study was the potential effects of MBP
exposure on germ cell development. Two main aspects were investi-
gated, germ cell number and differentiation. We investigated the
effect of fetal and neonatal MBP exposure in separate studies, as with
fetal exposure there was 12 weeks between cessation of treatment
and evaluation (around birth), in which effects of MBP might have
been recovered from, whereas this was not the case in neonatally-
treated animals. Previous studies in vivo in rats (Ferrara et al., 2006)
and in vitro in rats and humans (Lambrot et al., 2008) have shown that
certain phthalates (DBP/MBP, MEHP) can reduce fetal germ cell
number. We found that neither fetal nor neonatal exposure to MBP
had any signiﬁcant effect on germ cell numbers. However, in the neona-
tally treated animals, two of the ﬁve MBP-treated co-twins showed a
marked reduction in germ cell number compared with their control
co-twins. If this was due to MBP treatment, it is unclear why the remain-
ing three MBP-exposed animals did not show evidence for a similar
effect, so the difference could be unrelated to treatment.
Figure 3 Germ cell (GC) numbers (A) and OCT4þ cells as a percentage of total germ cell number (B) (a measure of germ cell differentiation) in
testes from 1–5-day-old marmosets after fetal exposure to 500 mg/kg/day MBP or in controls.
Values shown are for individuals (horizontal line ¼ mean); controls n ¼ 10, MBP n ¼ 6.
Figure 4 Germ cell (GC) proliferation in testes from 1–5-day-old
marmosets after fetal exposure to 500 mg/kg/day MBP or in controls.
Values shown are means+ SEM; controls n ¼ 10, MBP n ¼ 6.
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In terms of relevance to the human, the most important aspect of
germ cell development that we evaluated is their differentiation,
because incomplete fetal germ cell differentiation is thought to
underlie formation of CIS from which TGCT develops in adulthood
(Rajpert-de Meyts, 2006). A previous study in rats showed that fetal
DBP exposure delays (but does not prevent) germ cell differentiation
(Ferrara et al., 2006). The marmoset appears an excellent model for
the human as in both species perinatal germ cell differentiation is asyn-
chronous (in contrast to the rat), and the testes at birth contain a
mixed population of differentiated (VASAþ) and undifferentiated
(OCT4þ) germ cells (Mitchell et al., 2008). In marmosets (Mitchell
et al., 2008) and humans (Gaskell et al., 2004), the proportion of
OCT4þ germ cells declines progressively during fetal and neonatal
life, as gonocytes differentiate. In the present study, in newborn
control marmosets OCT4þ cells comprised 12% and VASAþ cells
87% of total germ cells. Although these proportions varied
considerably between animals, in control animals (n ¼ 10) OCT4þ
cells never comprised .29% of the total. If differentiation was
delayed by MBP exposure, the proportion of OCT4þ cells would be
increased, but we found no evidence for this in either fetally or neo-
natally MBP-exposed animals. However, in one marmoset exposed fetally
to MBP, the % OCT4þ cells was outside the control range (5-fold
Figure 5 Sertoli cell (SC) number (A) and germ cell (GC):SC ratio (B) in testes from 1–5-day-old marmosets after fetal exposure to 500 mg/kg/day
MBP or in controls.
Values shown are means+ SEM; controls n ¼ 6, MBP n ¼ 6.
Figure 6 Germ cell (GC) number in testes of 17–20-day-old mar-
mosets co-twins treated for the previous 14 days with either vehicle
(control twin) or 500 mg MBP/kg/day.
Figure 7 Representative testicular histology in adult marmosets
after fetal exposure to 500 mg/kg/day MBP (B) or in controls (A).
In MBP-exposed animals, seminiferous tubule structure and compo-
sition of seminiferous epithelium appeared comparable to controls.
Bar ¼ 50 mm.
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higher than the mean control value). This could indicate that OCT4
expression had been abnormally prolonged in some germ cells in this
animal, but we cannot exclude the possibility that it was simply at the
extreme of the normal range (based on 10 controls in this time period).
Another unusual ﬁnding in two marmosets after fetal MBP
exposure, was the occurrence of large germ cell clusters. These
mainly comprised cells immunopositive for OCT4, AP2g and C-KIT,
and therefore classiﬁed as undifferentiated gonocytes. Neither of
these animals was the one referred to above with an unusually high
proportion of OCT4þ germ cells. Aggregation of germ cells has pre-
viously been observed in the testes of fetal rats exposed to DBP,
due to withdrawal of Sertoli cell cytoplasm from around the germ
cells (Kleymenova et al., 2005). In the present study, however, germ
cell clusters were more localised within the cords and generally bor-
dered the basal lamina. Additionally, N-cadherin immunoexpression
in Sertoli cell cytoplasm around the clusters indicated normal Sertoli
cell-germ cell contact, unlike in the rat lesions. Exactly how these
germ cell clusters arose is unclear, and we found no previous refer-
ence to such clusters in the literature. One possibility is that they
are foci of clonal expansion, although no unusual pattern of Ki67
expression was observed within these areas.
Likewise it is not possible to conclude whether germ cells within
these clusters are abnormal. Clusters contained a much higher pro-
portion of OCT4þ cells than in the germ cells outside of the clusters,
perhaps suggesting that differentiation in these areas is occurring more
slowly than in the testes as a whole. If the clusters represent foci of
delayed development, it could be signiﬁcant in relation to origins of
CIS in humans (Rajpert-de Meyts, 2006), which is characterised by
expression of the pluripotency marker OCT4 and other markers of
undifferentiated or fetal germ cells such as AP2g and C-KIT, which
we also found in these germ cell clusters. However, since such clusters
were found in 2 out of 10 control animals, albeit smaller in size and with
much lower frequency, it is possible that the clusters in MBP-exposed
animals are merely at the extreme end of the normal range. For
certain, we found no such clusters or CIS-like cells in adulthood, but
as this is based on only ﬁve animals exposed in utero to MBP, animal
numbers may have been too low to detect this phenomenon or its con-
sequences (if any). In view of its importance, this needs clarifying.
Based on the present studies, we conclude that administration of
high doses of MBP to pregnant marmosets does not affect steroido-
genesis by the fetal testis during the critical period of the male pro-
gramming window, sufﬁcient to cause any detectable downstream
effects; nor is there any evidence for focal or wider testicular dysgen-
esis. This conclusion is based on a sufﬁcient number of animals (n ¼ 11
offspring in total) to provide a measure of conﬁdence. While these are
relatively small numbers, they should be considered in the context of
the high incidence of abnormalities found in rat studies using DBP.
Assuming that the high dose of MBP used in our study resulted in a
similar incidence, we would have expected to see several animals exhi-
biting one or more abnormality.
However, this conclusion rests on the assumption that all effects of
DBP are mediated via MBP in the marmoset, and we cannot exclude
the possibility that the lack of effects of MBP in the present study is
due to differences in metabolism of MBP by pregnant/fetal marmosets
as compared with rodents.
While the ﬁndings also do not demonstrate any overt abnormality in
germ cell numbers or development in MBP-exposed animals, some
changes were detected at birth in a minority of animals that could indi-
cate an effect, especially as only six animals were evaluated at birth for
these parameters; this requires clariﬁcation. This is particularly the
case in view of recent evidence indicating that MEHP has effects on
germ cells but not on steroidogenesis during exposure of the human
fetal testis in vitro (Lambrot et al., 2008).
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